The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer

Amy E. Baek, Erik Nelson

Research output: Contribution to journalReview article

Abstract

As the most common cancer in women, one in eight will develop invasive breast cancer over their lifetime making it the second most common cause of cancer-related death among women. Of the many known risk factors for developing breast cancer, obesity stands out as prominent and modifiable. Interestingly, elevated cholesterol is highly associated with obesity and has emerged as an independent risk factor for breast cancer onset and recurrence. This indicates that cholesterol also contributes to the breast cancer pathogenicity of obesity. This review highlights our current understanding of the mechanisms by which cholesterol impacts breast cancer. Key preclinical studies have been highlighted, including the discussion of homeostatic control of cholesterol levels, signaling by cholesterol metabolites through the estrogen receptors, cholesterol formation of lipid rafts and subsequent signaling, and the potential roles of cholesterol in creating a pro-inflammatory tumor microenvironment. Future directions and avenues for therapeutic exploitation are also considered.

Original languageEnglish (US)
Pages (from-to)219-228
Number of pages10
JournalHormones and Cancer
Volume7
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Cholesterol
Breast Neoplasms
Obesity
Tumor Microenvironment
Hypercholesterolemia
Estrogen Receptors
Virulence
Neoplasms
Lipids
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Cancer Research

Cite this

The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer. / Baek, Amy E.; Nelson, Erik.

In: Hormones and Cancer, Vol. 7, No. 4, 01.08.2016, p. 219-228.

Research output: Contribution to journalReview article

@article{4b0fa63efab74ab4b09a2c69cb2466d3,
title = "The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer",
abstract = "As the most common cancer in women, one in eight will develop invasive breast cancer over their lifetime making it the second most common cause of cancer-related death among women. Of the many known risk factors for developing breast cancer, obesity stands out as prominent and modifiable. Interestingly, elevated cholesterol is highly associated with obesity and has emerged as an independent risk factor for breast cancer onset and recurrence. This indicates that cholesterol also contributes to the breast cancer pathogenicity of obesity. This review highlights our current understanding of the mechanisms by which cholesterol impacts breast cancer. Key preclinical studies have been highlighted, including the discussion of homeostatic control of cholesterol levels, signaling by cholesterol metabolites through the estrogen receptors, cholesterol formation of lipid rafts and subsequent signaling, and the potential roles of cholesterol in creating a pro-inflammatory tumor microenvironment. Future directions and avenues for therapeutic exploitation are also considered.",
author = "Baek, {Amy E.} and Erik Nelson",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s12672-016-0262-5",
language = "English (US)",
volume = "7",
pages = "219--228",
journal = "Hormones and Cancer",
issn = "1868-8497",
publisher = "Springer US",
number = "4",

}

TY - JOUR

T1 - The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer

AU - Baek, Amy E.

AU - Nelson, Erik

PY - 2016/8/1

Y1 - 2016/8/1

N2 - As the most common cancer in women, one in eight will develop invasive breast cancer over their lifetime making it the second most common cause of cancer-related death among women. Of the many known risk factors for developing breast cancer, obesity stands out as prominent and modifiable. Interestingly, elevated cholesterol is highly associated with obesity and has emerged as an independent risk factor for breast cancer onset and recurrence. This indicates that cholesterol also contributes to the breast cancer pathogenicity of obesity. This review highlights our current understanding of the mechanisms by which cholesterol impacts breast cancer. Key preclinical studies have been highlighted, including the discussion of homeostatic control of cholesterol levels, signaling by cholesterol metabolites through the estrogen receptors, cholesterol formation of lipid rafts and subsequent signaling, and the potential roles of cholesterol in creating a pro-inflammatory tumor microenvironment. Future directions and avenues for therapeutic exploitation are also considered.

AB - As the most common cancer in women, one in eight will develop invasive breast cancer over their lifetime making it the second most common cause of cancer-related death among women. Of the many known risk factors for developing breast cancer, obesity stands out as prominent and modifiable. Interestingly, elevated cholesterol is highly associated with obesity and has emerged as an independent risk factor for breast cancer onset and recurrence. This indicates that cholesterol also contributes to the breast cancer pathogenicity of obesity. This review highlights our current understanding of the mechanisms by which cholesterol impacts breast cancer. Key preclinical studies have been highlighted, including the discussion of homeostatic control of cholesterol levels, signaling by cholesterol metabolites through the estrogen receptors, cholesterol formation of lipid rafts and subsequent signaling, and the potential roles of cholesterol in creating a pro-inflammatory tumor microenvironment. Future directions and avenues for therapeutic exploitation are also considered.

UR - http://www.scopus.com/inward/record.url?scp=84961620286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961620286&partnerID=8YFLogxK

U2 - 10.1007/s12672-016-0262-5

DO - 10.1007/s12672-016-0262-5

M3 - Review article

C2 - 27020054

AN - SCOPUS:84961620286

VL - 7

SP - 219

EP - 228

JO - Hormones and Cancer

JF - Hormones and Cancer

SN - 1868-8497

IS - 4

ER -